BECTON DICKINSON & CO
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The table below sets forth certain information regarding our purchases of common stock of BD during the quarter ended March 31, 2025.
Issuer Purchases of Equity Securities
| For the three months ended March 31, 2025 | Total Number ofShares Purchased (1) | Average PricePaid perShare | Total Number ofShares Purchasedas Part ofPubliclyAnnounced Plansor Programs | Maximum Numberof Shares that MayYet Be PurchasedUnder the Plans orPrograms (2) |
|---|---|---|---|---|
| January 1 – 31, 2025 (3) | 620,347 | $230.37 | 619,071 | 13,426,039 |
| February 1 – 28, 2025 | 344 | 244.13 | — | 13,426,039 |
| March 1 – 31, 2025 | — | — | — | 13,426,039 |
| Total | 620,691 | $230.38 | 619,071 | 13,426,039 |
(1)Includes 1,620 shares purchased during the quarter in open market transactions by the trust relating to BD’s Deferred Compensation and Retirement Benefit Restoration Plan and 1996 Directors’ Deferral Plan.
(2)Includes 3,426,039 shares under a repurchase program authorized by the Board of Directors on November 3, 2021, and 10 million shares under a repurchase program authorized by the Board of Directors on January 28, 2025. There is no expiration date for either program.
(3)Shares purchased includes 619,071 shares received upon final settlement of a $750 million accelerated share repurchase (“ASR”) agreement, which was executed in December 2024. The total average price paid per share in the table above reflects the volume weighted average price of BD's shares over the term of the ASR agreement. Additional disclosures regarding this transaction are provided in Note 3 of the Notes to Condensed Consolidated Financial Statements in this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.